-
Lilly's Trial Studying Higher Doses of Trulicity® (dulaglutide) Meets Primary Endpoint
americanpharmaceuticalreview
June 27, 2019
Eli Lilly and Company's trial studying higher investigational doses of Trulicity® (dulaglutide) met its primary efficacy endpoint of superiority, significantly reducing A1C from baseline in people with type 2 diabetes, compared to once-weekly Trulicity 1.
-
Diabetes Outcomes Similar Regardless of Primary Provider
drugs
June 26, 2019
Diabetes Outcomes Similar Regardless of Primary Provider。
-
Job cuts limit cardiovascular and diabetes research and development
europeanpharmaceuticalreview
June 26, 2019
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
-
Global diabetes drug market expected to rise 3.6 percent
europeanpharmaceuticalreview
June 26, 2019
A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
-
Anxiety With Type 2 Diabetes Tied to High-Cost Health Care Use
drugs
June 25, 2019
Anxiety With Type 2 Diabetes Tied to High-Cost Health Care Use.
-
Risk Factors ID'd for Atrial Fibrillation With Type 1 Diabetes
drugs
June 21, 2019
Risk Factors ID'd for Atrial Fibrillation With Type 1 Diabetes.
-
Type 2 diabetes treatment approved for children and adolescents
europeanpharmaceuticalreview
June 20, 2019
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.
-
FDA Approves Victoza Injection for Children 10 Years and Older with Type 2 Diabetes
drugs
June 19, 2019
FDA Approves Victoza Injection for Children 10 Years and Older with Type 2 Diabetes.
-
FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes
drugs
June 18, 2019
FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes.
-
Common Infant Rotavirus Vaccine May Also Shield Kids From Type 1 Diabetes
drugs
June 17, 2019
Common Infant Rotavirus Vaccine May Also Shield Kids From Type 1 Diabetes.